Related Experiment Video
Updated: Aug 4, 2026

In Vitro Analysis of PDZ-dependent CFTR Macromolecular Signaling Complexes
Published on: August 13, 2012
A(2) adenosine receptors regulate CFTR through PKA and PLA(2)
1Department of Human Genetics, University of Alabama at Birmingham, 35233, USA.
Abstract:
We investigated adenosine (Ado) activation of the cystic fibrosis transmembrane conductance regulator (CFTR) in vitro and in vivo. A(2B) Ado receptors were identified in Calu-3, IB-3-1, COS-7, and primary human airway cells. Ado elevated cAMP in Calu-3, IB-3-1, and COS-7 cells and activated protein kinase A-dependent halide efflux in Calu-3 cells. Ado promoted arachidonic acid release from Calu-3 cells, and phospholipase A(2) (PLA(2)) inhibition blocked Ado-activated halide efflux in Calu-3 and COS-7 cells expressing CFTR. Forskolin- and beta(2)-adrenergic receptor-stimulated efflux were not affected by the same treatment. Cytoplasmic PLA(2) (cPLA(2)) was identified in Calu-3, IB-3-1, and COS-7 cells, but cPLA(2) inhibition did not affect Ado-stimulated cAMP concentrations. In cftr(+) and cftr(-/-) mice, Ado stimulated nasal Cl(-) secretion that was CFTR dependent and sensitive to A(2) receptor and PLA(2) blockade. In COS-7 cells transiently expressing DeltaF508 CFTR, Ado activated halide efflux. Ado also activated G551D CFTR-dependent halide efflux when combined with arachidonic acid and phosphodiesterase inhibition. In conclusion, PLA(2) and protein kinase A both contribute to A(2) receptor activation of CFTR, and components of this signaling pathway can augment wild-type and mutant CFTR activity.
Insights
Adenosine (Ado) activates cystic fibrosis transmembrane conductance regulator (CFTR) via A(2B) receptors, involving phospholipase A(2) (PLA(2)) and protein kinase A. This pathway enhances both wild-type and mutant CFTR activity.
Area of Science:
- Cell Biology
- Molecular Physiology
- Respiratory Medicine
Background:
- Adenosine (Ado) is a key signaling molecule in various physiological processes.
- The cystic fibrosis transmembrane conductance regulator (CFTR) is a crucial ion channel implicated in cystic fibrosis.
- Understanding CFTR regulation is vital for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the role of adenosine (Ado) in activating the cystic fibrosis transmembrane conductance regulator (CFTR).
- To elucidate the specific signaling pathways involved in Ado-mediated CFTR activation, including receptors and enzymes.
- To assess the potential of this pathway to modulate both wild-type and mutant CFTR function.
Main Methods:
- In vitro studies using various cell lines (Calu-3, IB-3-1, COS-7) and primary human airway cells.
- In vivo experiments utilizing wild-type and CFTR-deficient mice.
- Measurement of intracellular cAMP levels, halide efflux, and arachidonic acid release.
- Pharmacological inhibition of specific receptors (A(2B)) and enzymes (PLA(2), cPLA(2)).
- Expression studies involving wild-type, DeltaF508, and G551D mutant CFTR.
Main Results:
- A(2B) adenosine receptors were identified in airway cells and mediated Ado-induced cAMP elevation and protein kinase A-dependent halide efflux.
- Adenosine stimulated arachidonic acid release, and phospholipase A(2) (PLA(2)) inhibition blocked Ado-activated halide efflux, indicating PLA(2) involvement.
- Ado stimulated CFTR-dependent nasal chloride secretion in mice, sensitive to A(2) receptor and PLA(2) blockade.
- Adenosine activated halide efflux in cells expressing both wild-type and mutant CFTR (DeltaF508, G551D), with the latter requiring additional factors.
Conclusions:
- Phospholipase A(2) (PLA(2)) and protein kinase A (PKA) are essential components of A(2B) receptor-mediated activation of CFTR.
- This signaling pathway can enhance the activity of both wild-type and mutant forms of CFTR.
- Targeting this adenosine-mediated pathway presents a potential therapeutic avenue for cystic fibrosis and other CFTR-related disorders.
Related Concept Videos
G-Protein Gated Ion Channels
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Two...
cAMP-dependent Protein Kinase Pathways
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...

